当前位置:
X-MOL 学术
›
Cancer Cell
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cavity macrophages stop anti-tumor T cells
Cancer Cell ( IF 50.3 ) Pub Date : 2021-07-12 , DOI: 10.1016/j.ccell.2021.06.007 Paulo C Rodriguez 1 , Brian Ruffell 2
中文翻译:
空腔巨噬细胞阻止抗肿瘤 T 细胞
更新日期:2021-07-12
Cancer Cell ( IF 50.3 ) Pub Date : 2021-07-12 , DOI: 10.1016/j.ccell.2021.06.007 Paulo C Rodriguez 1 , Brian Ruffell 2
Affiliation
Precisely how macrophages regulate response to immunotherapy remains unclear. In this issue of Cancer Cell, Chow et al. demonstrate a tumor-promoting role of TIM-4+ cavity macrophages which affects the response of metastatic malignancies to immunotherapy. Specifically, TIM-4+ macrophages engage with phosphatidylserine-expressing cytotoxic T lymphocytes, inhibiting their activity even during PD-1 blockade.
中文翻译:
空腔巨噬细胞阻止抗肿瘤 T 细胞
巨噬细胞究竟如何调节对免疫疗法的反应仍不清楚。在本期的Cancer Cell中,Chow 等人。证明 TIM-4 +腔巨噬细胞的肿瘤促进作用影响转移性恶性肿瘤对免疫疗法的反应。具体来说,TIM-4 +巨噬细胞与表达磷脂酰丝氨酸的细胞毒性 T 淋巴细胞结合,即使在 PD-1 阻断期间也会抑制它们的活性。